Personal Data for Public Benefit: The Regulatory Determinants of Social Licence for Technologically Enhanced Antimicrobial Resistance Surveillance.
- Publication Type:
- Journal Article
- Citation:
- J Law Med, 2023, 30, (1), pp. 179-190
- Issue Date:
- 2023-05
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
(2023) 30 Journal of Law and Medicine 179.pdf | Accepted version | 101.25 kB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Carter, DJ | |
dc.contributor.author | Byrne, MK | |
dc.contributor.author | Djordjevic, SP | |
dc.contributor.author | Robertson, H | |
dc.contributor.author | Labbate, M | |
dc.contributor.author | Morgan, BS | |
dc.contributor.author |
Billington, L https://orcid.org/0000-0003-0011-1221 |
|
dc.date.accessioned | 2023-09-29T05:23:56Z | |
dc.date.available | 2023-09-29T05:23:56Z | |
dc.date.issued | 2023-05 | |
dc.identifier.citation | J Law Med, 2023, 30, (1), pp. 179-190 | |
dc.identifier.issn | 1320-159X | |
dc.identifier.uri | http://hdl.handle.net/10453/172386 | |
dc.description.abstract | Technologically enhanced surveillance systems have been proposed for the task of monitoring and responding to antimicrobial resistance (AMR) in both human, animal and environmental contexts. The use of these systems is in their infancy, although the advent of COVID-19 has progressed similar technologies in response to that pandemic. We conducted qualitative research to identify the Australian public's key concerns about the ethical, legal and social implications of an artificial intelligence (AI) and machine learning-enhanced One Health AMR surveillance system. Our study provides preliminary evidence of public support for AI/machine learning-enhanced One Health monitoring systems for AMR, provided that three main conditions are met: personal health care data must be deidentified; data use and access must be tightly regulated under strong governance; and the system must generate high-quality, reliable analyses to guide trusted health care decision-makers. | |
dc.format | ||
dc.language | eng | |
dc.relation.ispartof | J Law Med | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 11 Medical and Health Sciences, 18 Law and Legal Studies, 22 Philosophy and Religious Studies | |
dc.subject.classification | 4203 Health services and systems | |
dc.subject.classification | 4804 Law in context | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Artificial Intelligence | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Anti-Bacterial Agents | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Drug Resistance, Bacterial | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Anti-Bacterial Agents | |
dc.subject.mesh | Drug Resistance, Bacterial | |
dc.subject.mesh | Artificial Intelligence | |
dc.subject.mesh | Australia | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Artificial Intelligence | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Anti-Bacterial Agents | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Drug Resistance, Bacterial | |
dc.title | Personal Data for Public Benefit: The Regulatory Determinants of Social Licence for Technologically Enhanced Antimicrobial Resistance Surveillance. | |
dc.type | Journal Article | |
utslib.citation.volume | 30 | |
utslib.location.activity | Australia | |
utslib.for | 11 Medical and Health Sciences | |
utslib.for | 18 Law and Legal Studies | |
utslib.for | 22 Philosophy and Religious Studies | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Law | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science | |
pubs.organisational-group | /University of Technology Sydney/Strength - AIMI - Australian Institute for Microbiology & Infection | |
utslib.copyright.status | closed_access | * |
dc.date.updated | 2023-09-29T05:23:55Z | |
pubs.issue | 1 | |
pubs.publication-status | Published | |
pubs.volume | 30 | |
utslib.citation.issue | 1 |
Abstract:
Technologically enhanced surveillance systems have been proposed for the task of monitoring and responding to antimicrobial resistance (AMR) in both human, animal and environmental contexts. The use of these systems is in their infancy, although the advent of COVID-19 has progressed similar technologies in response to that pandemic. We conducted qualitative research to identify the Australian public's key concerns about the ethical, legal and social implications of an artificial intelligence (AI) and machine learning-enhanced One Health AMR surveillance system. Our study provides preliminary evidence of public support for AI/machine learning-enhanced One Health monitoring systems for AMR, provided that three main conditions are met: personal health care data must be deidentified; data use and access must be tightly regulated under strong governance; and the system must generate high-quality, reliable analyses to guide trusted health care decision-makers.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph